Netflix's Medical Investigation Docuseries 'Diagnosis'
Based on Dr. Lisa Sanders’ popular column in The New York Times Magazine, Diagnosis follows various patients on their respective journeys toward finding a diagnosis, and potentially a cure, for their mysterious illnesses.
Aug 19, 2019 | By Kelly Lawler | USA Today
Amid documentaries with serial killers, insights into the broken criminal-justice system and environmental disasters, it’s nice to watch one that inspires rather than saddens.
That’s especially true on Netflix, which has carved out a reputation for great true-crime docs since “Making a Murderer” became a sensation in 2015. But the streaming service may have found the trendy new documentary subgenre in its latest series, “Diagnosis.”
The seven-episode “Diagnosis” (now streaming is based on the New York Times Magazine column by Lisa Sanders, a New York City physician who chronicles strange medical mysteries. But the series doesn’t just tell stories about hard-to-diagnose patients; instead, Sanders crowd sources the cases after detailing patients’ symptoms. (TNT is trying a similar format with Ann Curry’s “Chasing the Cure.”)
TRNDS 2019
University of Rochester
Saunders Research Building
Helen Wood Hall Auditorium
255 Crittenden Blvd
Rochester, NY 14642
Date: Friday, September 13
Time: 7:30 am – 4:00pm
TRNDS News
Sign-up for TRNDS updates and rare disease news
-
New Grants will Accelerate Clinical Trials in Rare Neurological Disorders
-
Neurogene Offers Access to Genetic Testing for Lysosomal Storage Disease
-
NIH launches 5-year, $10 million study on acute flaccid myelitis
-
Study refines ALS risk among first-degree relatives of patients with disease
-
NCATS Director Warns of 'Poorly Understood Public Health Implications of Rare Diseases'
-
Speeding Up Drug Discovery for Brain Diseases
-
NIH-Funded Project Aims to Build a ‘Google’ for Biomedical Data
-
Rare Disease Groups Seek Public Support to Renew Newborn Screening Act in Senate
-
(Podcast) Get to know Jayne Gershkowitz, Chief Patient Advocate at Amicus Therapeutics
-
Meet TRNDS 2019 Speaker PJ Brooks
-
Rare Pediatric Disease PRVs: FDA Updates Guidance
-
Neurogene Opens Natural History Study of CLN7, CLN5 Diseases at UT Southwestern
-
C-Path and NORD Collaborate to Launch Rare Disease Data Platform
-
Meet TRNDS Speaker Tauna Batiste
-
HD Patients Prefer Less Invasive, No-Placebo Gene Therapy Trials
-
Evidation & Eli Lilly Study Uses Apple Devices, Apps to Predict Cognitive Impairment
-
'Dr. Google' Helps Some Patients Diagnose a Rare Disease
-
Antisense Drugs for HD, ALS & Prion Could Meet the Need for Brain Treatments
-
Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome
-
Netflix's Medical Investigation Docuseries 'Diagnosis'
-
NIH All of Us Project Tops 270,000 Sign-ups
-
FDA Cancer Office Taps Syapse for Real-world Evidence Development
-
Gene Linked to Rare Neurological Disorder May Play a Role in Alzheimer’s
-
Gene Therapy Developers Issue Principles for Human Genome Editing
-
Forget Single Genes: CRISPR Now Cuts & Splices Whole Chromosomes
-
TRNDS Speaker Benjamin Schlatka, MC10
-
TRNDS Speaker Danielle Edwards, Jett Foundation
-
His daughter has a rare disorder. He’s developing a novel gene therapy.
-
A Doctor Tested a New Treatment on Himself, Now it's Saving Other Lives
-
Study Presents Clinical, Genetic Landscape of Pompe Disease
Room Block
Hilton Garden Inn
Rochester/University
Medical Center
30 Celebration Drive
Rochester, NY 14620
Phone: 585-424-4404
TRNDS Rate: $149/night